By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    physical health
    5 Ways Playing Games Can Improve Neural and Physical Health
    September 9, 2022
    Reasons For Hair Loss and Its Treatment
    Reasons For Hair Loss and Its Treatment
    February 16, 2022
    healthcare organization
    5 Actionable Strategies For Healthcare Organizations
    August 15, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    email marketing in healthcare
    Harnessing the Power of Email Marketing in Healthcare
    October 26, 2023
    healthcare claims
    The Role of Communication in Resolving Complex Workers’ Compensation Claims in Healthcare Settings
    September 22, 2024
    Wounds and Wisdom: What Motorcycle Accidents Teach Us About Health and Healing
    Wounds and Wisdom: What Motorcycle Accidents Teach Us About Health and Healing
    February 12, 2025
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Unintended Consequences of Changing the Current 510K System for “Moderate Risk” Devices
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Unintended Consequences of Changing the Current 510K System for “Moderate Risk” Devices
BusinessMedical Devices

Unintended Consequences of Changing the Current 510K System for “Moderate Risk” Devices

DavidEWilliams
Last updated: August 6, 2011 7:57 am
DavidEWilliams
Share
6 Min Read
SHARE

 

 

On July 29 an expert panel assembled by the Institute of Medicine found that the current regulatory framework for “substantially equivalent” devices (known as the FDA 510K process) was flawed and called for it to be replaced with a system better designed to protect the public’s health.  The findings have some merit, but the recommendations have the potential to substantially decrease innovation at a time when more, rather than less, innovation is required to increase the quality and reduce the cost of health care in the US.

It should be noted that the current 510K system is for “moderate risk” devices only.  The creation of an artificial kidney, for instance, would be viewed as a “high risk” device. and would be required to undergo exhaustive human clinical trials to be granted approval by the FDA.  An endoscope with a better optical camera enabling it to find more anomalies during an endoscopic procedure is considered “moderate risk” and  requires that the manufacturer show that the device is “substantially equivalent” to existing products in the market.

More Read

FDA Gives Approval for Lap-Band Use With Less Obese Patients
Unnecessary Regulations that Increase Prescription Drug Costs
The Heart of Content Marketing for Life Sciences: Start with a Powerful Story
New Medical Technologies at Startups
Personalized Medicine and a Cure for Cancer

But the process doesn’t stop there.  Companies are required to follow very detailed processes once a product is approved to show that their product is compliant with FDA regulations.  These processes require a company to register all customer complaints and show that they have a process for dealing with them.  Additionally, any claims of injury of a patient by the device need to be immediately brought to the attention of the FDA.  There is a final “stick” used by the FDA that makes willful acts of omission about the safety of a device a criminal penalty, with the CEO of the company being personally liable.

Further, good physicians don’t just gravitate to new products unless there is a substantial body of evidence to show the product has clinical utility.  This comes from clinical trials by the physician community.  While some notable companies have abused this practice by paying physicians to promote their products, this is the exception, not the rule.  Recent disclosure practices, required by professional societies and academic institutions, are working to root out the problem.  This practice, however, is independent of what process the device goes through to obtain approval.

The biggest unintended consequence of overhauling the current 510K process is its effect on investment in the industry.  Investment firms (and investment committees in large corporations) usually look at four types of risk –market, technical, regulatory and reimbursement– before deciding to make investments.  Obviously, the first two are independent of regulatory requirements.  The last two, however, are actually related.

A new device that is required to go through full clinical trials (known as a “PMA”) can often require $50 million to $100 million in investment to bring it to market and significantly more to become profitable.  A device deemed substantially equivalent and utilizing the 510K process requires approximately half that amount.  Note that the difference isn’t the amount spent on determining the safety of the device, but rather the huge cost of carrying a non-income producing staff while the studies are completed.

Obviously, while there are still investments being made in companies requiring $100 million to get to market, these are becoming less common.  In fact, many of the venture capital firms that focused on medical device investing exclusively have either gone out of business or shifted their investment strategy to other markets.  This has been driven, in large part, by the difficult reimbursement environment, which appears to be driving down reimbursement with each passing day.  If an investor doesn’t have the high likelihood of making a reasonable rate of return after nearly a decade of investment, they will look for other places to invest.

While economics should never be a good justification to enable devices that are unsafe to enter the market, the current 510K process is designed to be used for moderate risk devices and carries with it considerable penalties (financial and criminal) to minimize the likelihood of such risk.  Furthermore, these devices are being used by physicians who aren’t going to take safety risks with an unproven product.  Physicians will buy these devices for research studies initially, until they see a body of evidence that convinces them of the merit (and lack of harm) of these devices.

Rather than throw the baby out with the bath water, the Committee should contemplate some “tweaks” to the existing system that might improve safety.  I’ll suggest some potential improvements to the current system in my next blog post.

This is a guest post from Rick Lifsitz, a colleague of mine from MedPharma Partners and a serial entrepreneur .

 

 


TAGGED:FDAhealthcare businessmedical devices
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025
Learn how to Renew your Medical Card in West Virginia
Learn how to Renew your Medical Card in West Virginia
Health
May 15, 2025
Dr. Klaus Rentrop Shares Acute Myocardial Infarction heart treatment
Dr. Klaus Rentrop Shares Acute Myocardial Infarction
Cardiology
May 13, 2025

You Might also Like

Why You Should Care About Your Personal Health Record and Access to Your Data

June 13, 2014

When Onboard Monitoring Comes to Health Insurance

June 15, 2012

The FDA Patient Network Website: Pretty Darn Patient-Centered

May 15, 2013

Essential Features of Today’s Hospital Websites

May 4, 2016
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?